The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Epidemiology of hepatocellular carcinoma in USA
Abstract
Hepatocellular carcinoma (HCC) is increasing in frequency the USA. Age‐adjusted incidence, hospitalization, and mortality rates have doubled over the past two decades. There are striking differences in the incidence of HCC related to age, gender, race, and geographic region. Although it remains an affliction of the elderly (mean age 65), there has been a considerable shift toward younger cases. There is a birth cohort effect with those born after 1945. Men are affected three times more frequently than women, Asians two times more than African American and Hispanic people, who are affected two times more often than Caucasians. However, the recent increase has disproportionately affected Caucasian (and Hispanic) men between ages 45 and 65. Hepatitis C virus (HCV) infection acquired 2–4 decades ago explains at least half of the observed increase in HCC; HCV‐related HCC is likely tocontinue to increase for the next decade. A variable but significant proportion of cases (15–50%) do not have evidence for the risk factors of either viral hepatitis or heavy alcohol consumption. Insulin resistance syndrome manifesting as obesity and diabetes is emerging as a risk factor for HCC in the USA and may operate through the formation of non‐alcoholic fatty liver disease (NAFLD); however, its effect on the current trend in HCC remains unclear. While there has been a small recent improvement in survival, it remains generally dismal (median 8 months). Population‐based data in the USA indicate low application rate of HCC potentially curative therapy and marked regional differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Self-citationYoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Self-citationEl–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Self-citationHassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Estimating future hepatitis C morbidity, mortality, and costs in the United States
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 567
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Self-citationEl-Serag, H. B., Mason, A. C., & Key, C. (2001) · Hepatology · doi:10.1053/jhep.2001.21041 · Cited by 353
Self-citationEpidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
Self-citationEl-Serag, H. B., Siegel, A. B., Davila, J. A., Shaib, Y. H., Cayton-Woody, M., McBride, R., & McGlynn, K. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.002 · Cited by 232
Self-citationYu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status
Di Bisceglie, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00552-5 · Cited by 189
Yu, M. C., Tong, M. J., Coursaget, P., Ross, R. K., Govindarajan, S., & Henderson, B. E. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1038 · Cited by 175
The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.
Bisceglie, A. M. D., Order, S. E., Klein, J., Waggoner, J. G., Sjögren, M. H., Kuo, G. C., Houghton, M., Choo, Q. L., & Hoofnagle, J. H. (1991) · PubMed · Cited by 150
Hassan, M. M., Frome, A., Patt, Y. Z., et al. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200209000-00013 · Cited by 130
Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States
Kim, W. R., Gores, G. J., BENSON, J., Therneau, T. M., & MELTONIII, L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.001 · Cited by 106
Non-alcoholic fatty liver and insulin resistance: a cause–effect relationship?
Bugianesi, E., Zannoni, C., Vanni, E., Marzocchi, R., & Marchesini, G. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.12.008 · Cited by 101
Goodgame, B., Shaheen, N. J., Galanko, J., & El-Serag, H. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07678.x · Cited by 72
Self-citationHepatocellular carcinoma incidence in Florida
Shea, K. A., Fleming, L. E., Wilkinson, J. D., Wohler‐Torres, B., & McKinnon, J. A. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<1046::aid-cncr1096>3.0.co;2-2 · Cited by 27
Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
Shea, K. A., Fleming, L. E., Wilkinson, J. D., et al. (2001) · PubMed · Cited by 25
Cited by
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global patterns of cancer incidence and mortality rates and trends
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0437 · Cited by 2,778
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Self-citationMorgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Metadata
- Authors
- El‐Serag, H. B.
- Venue
- Hepatology Research
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 37
- Issue
- s2
- Pages
- S88-94
- ISSN
- 1386-6346 (ISSN-L)
- 1872-034X
- OpenAlex
- W2133423870
- Cited by
- 320
- References
- 25
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.